In a significant stride toward preventive healthcare, the Government of India has successfully screened over 10 crore 18 lakh women for cervical cancer under the combined efforts of the Ayushman Arogya Mandirs and the National Health Mission (NHM). This large-scale screening initiative is part of the government’s population-based approach for the prevention, early detection, and management of Non-Communicable Diseases (NCDs).
In a statement issued by the Ministry of Health and Family Welfare, officials emphasized that the screening primarily targets women in the 30 to 65 age group, who are at a higher risk of developing cervical cancer. The screening process uses Visual Inspection with Acetic Acid (VIA) — a low-cost, effective method conducted at Sub-Health Centres and Primary Health Centres across the country.
According to the ministry, VIA-positive cases are systematically referred to higher-level health facilities for detailed diagnostic evaluation and follow-up. This referral system ensures that potentially serious cases are managed efficiently and on time, preventing disease progression and improving health outcomes.
The ministry lauded the initiative as a milestone in India's public health system, reflecting the government's strong commitment to universal and preventive healthcare. The Ayushman Arogya Mandirs, envisioned as part of the Ayushman Bharat scheme, have been pivotal in making healthcare accessible at the grassroots level.
“This remarkable achievement not only highlights the scale of the initiative but also underscores the success of our ongoing efforts to integrate preventive health services into primary care systems,” the ministry stated.
The cervical cancer screening campaign aligns with the broader objectives of the Ayushman Bharat Health and Wellness Centres (AB-HWCs), aiming to reduce the burden of NCDs and ensure early intervention, especially in underserved and rural populations.
With continued government focus on health awareness, timely diagnostics, and structured referrals, the initiative is expected to significantly contribute to reducing mortality and morbidity associated with cervical cancer in India.
Leave Your Comment